Home › Funds › SHAH CAPITAL MANAGEMENT › NVAX
SHAH CAPITAL MANAGEMENT position in NVAX
NOVAVAX INC · Health Care
SHAH CAPITAL MANAGEMENT reported holding 12,173,481 shares of NVAX (NOVAVAX INC) in its Q3 2026 13F filing — a position valued at US$131.6M, representing 21.75% of its reported portfolio and ranking #2 among its reported holdings. SHAH CAPITAL MANAGEMENT has disclosed NVAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How SHAH CAPITAL MANAGEMENT's NVAX position evolved
SHAH CAPITAL MANAGEMENT first disclosed a stake in NVAX in Q3 2023 at 6,330,756 shares (US$45.8M). The position peaked in Q2 2026 at 14,165,577 shares, worth US$133.4M. Across 13 filings, SHAH CAPITAL MANAGEMENT increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 12,173,481 shares valued at US$131.6M — a reduction of -1,992,096 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.33M | $45.83M | New |
| Q4 2023 | 7.78M | $37.35M | Add |
| Q1 2024 | 8.12M | $38.80M | Add |
| Q2 2024 | 9.66M | $122.32M | Add |
| Q3 2024 | 9.82M | $123.97M | Add |
| Q4 2024 | 11.15M | $89.64M | Add |
| Q1 2025 | 11.13M | $71.36M | Hold |
| Q2 2025 | 11.51M | $72.52M | Add |
| Q3 2025 | 11.81M | $102.41M | Add |
| Q4 2025 | 14.56M | $97.84M | Add |
| Q1 2026 | 14.85M | $120.84M | Add |
| Q2 2026 | 14.17M | $133.44M | Reduce |
| Q3 2026 | 12.17M | $131.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVAX and 13F data
NVAX (NOVAVAX INC) is a Health Care company. 26 other funds we track also report a position in NVAX — the largest reported positions include Sanofi (US$64.8M), Coatue Management (US$36.1M), COATUE MANAGEMENT LLC (US$36.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVAX
- Sanofi 6.88M sh · $64.81M · Q2 2026
- Coatue Management 3.84M sh · $36.14M · Q2 2026
- COATUE MANAGEMENT LLC 3.84M sh · $36.14M · Q2 2026
- TSP Capital Management Group, LLC 1.43M sh · $15.48M · Q3 2026
More on SHAH CAPITAL MANAGEMENT
FAQ
How long has SHAH CAPITAL MANAGEMENT held NVAX?
SHAH CAPITAL MANAGEMENT has disclosed NVAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SHAH CAPITAL MANAGEMENT's current position in NVAX?
As of Q3 2026, SHAH CAPITAL MANAGEMENT holds 12.17M shares of NVAX (NOVAVAX INC), valued at $131.60M, representing 21.75% of its reported portfolio and ranking #2.
Has SHAH CAPITAL MANAGEMENT been buying or selling NVAX?
In the latest 13F filing (Q3 2026), SHAH CAPITAL MANAGEMENT reduced its position in NVAX. The position peaked in Q2 2026 at 14.17M shares.
Which other funds hold NVAX?
Other major institutional holders of NVAX include Sanofi, Coatue Management, COATUE MANAGEMENT LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.